230 related articles for article (PubMed ID: 36693363)
41. Novel fusion sarcomas including targetable NTRK and ALK.
Chen T; Wang Y; Goetz L; Corey Z; Dougher MC; Smith JD; Fox EJ; Freiberg AS; Flemming D; Fanburg-Smith JC
Ann Diagn Pathol; 2021 Oct; 54():151800. PubMed ID: 34464935
[TBL] [Abstract][Full Text] [Related]
42. Heterologous and rare homologous sarcomas of the uterine corpus: a clinicopathologic review.
Fadare O
Adv Anat Pathol; 2011 Jan; 18(1):60-74. PubMed ID: 21169739
[TBL] [Abstract][Full Text] [Related]
43. The value of immunohistochemistry in the diagnosis of soft tissue sarcomas.
Carbone A; Gloghini A; Volpe R
Ann Oncol; 1992 Apr; 3 Suppl 2():S51-4. PubMed ID: 1622866
[TBL] [Abstract][Full Text] [Related]
44. Molecular Pathogenesis and Diagnostic, Prognostic and Predictive Molecular Markers in Sarcoma.
Mariño-Enríquez A; Bovée JV
Surg Pathol Clin; 2016 Sep; 9(3):457-73. PubMed ID: 27523972
[TBL] [Abstract][Full Text] [Related]
45. Fluorescence in situ hybridization for MDM2 gene amplification as a diagnostic tool in lipomatous neoplasms.
Weaver J; Downs-Kelly E; Goldblum JR; Turner S; Kulkarni S; Tubbs RR; Rubin BP; Skacel M
Mod Pathol; 2008 Aug; 21(8):943-9. PubMed ID: 18500263
[TBL] [Abstract][Full Text] [Related]
46. Pleomorphic Sarcomas: The State of the Art.
Carvalho SD; Pissaloux D; Crombé A; Coindre JM; Le Loarer F
Surg Pathol Clin; 2019 Mar; 12(1):63-105. PubMed ID: 30709449
[TBL] [Abstract][Full Text] [Related]
47. Extensive survey of STAT6 expression in a large series of mesenchymal tumors.
Demicco EG; Harms PW; Patel RM; Smith SC; Ingram D; Torres K; Carskadon SL; Camelo-Piragua S; McHugh JB; Siddiqui J; Palanisamy N; Lucas DR; Lazar AJ; Wang WL
Am J Clin Pathol; 2015 May; 143(5):672-82. PubMed ID: 25873501
[TBL] [Abstract][Full Text] [Related]
48. High-grade Endometrial Stromal Sarcoma: Morphologic and Clinical Features, the Role of Immunohistochemistry and Fluorescence in Situ Hybridization in Diagnosis.
Alkanat NE; Uner A; Usubutun A
Int J Surg Pathol; 2023 Aug; 31(5):521-531. PubMed ID: 35506912
[No Abstract] [Full Text] [Related]
49. PDGFRA Immunohistochemistry Predicts PDGFRA Mutations in Gastrointestinal Stromal Tumors.
Papke DJ; Forgó E; Charville GW; Hornick JL
Am J Surg Pathol; 2022 Jan; 46(1):3-10. PubMed ID: 33859072
[TBL] [Abstract][Full Text] [Related]
50. NKX2.2 immunohistochemistry in the distinction of Ewing sarcoma from cytomorphologic mimics: Diagnostic utility and pitfalls.
Russell-Goldman E; Hornick JL; Qian X; Jo VY
Cancer Cytopathol; 2018 Nov; 126(11):942-949. PubMed ID: 30376220
[TBL] [Abstract][Full Text] [Related]
51. A selective screening platform reveals unique global expression patterns of microRNAs in a cohort of human soft-tissue sarcomas.
Yu PY; Balkhi MY; Ladner KJ; Alder H; Yu L; Mo X; Kraybill WG; Guttridge DC; Iwenofu OH
Lab Invest; 2016 Apr; 96(4):481-91. PubMed ID: 26878133
[TBL] [Abstract][Full Text] [Related]
52. Targeted RNA expression profiling identifies high-grade endometrial stromal sarcoma as a clinically relevant molecular subtype of uterine sarcoma.
Momeni-Boroujeni A; Mohammad N; Wolber R; Yip S; Köbel M; Dickson BC; Hensley ML; Leitao MM; Antonescu CR; Benayed R; Ladanyi M; Lee CH; Chiang S
Mod Pathol; 2021 May; 34(5):1008-1016. PubMed ID: 33077922
[TBL] [Abstract][Full Text] [Related]
53. A comparative study of P53/MDM2 genes alterations and P53/MDM2 proteins immunoreactivity in soft-tissue sarcomas.
Rieske P; Bartkowiak JK; Szadowska AM; Olborski B; Harezga-Bal B; Debiec-Rychter M
J Exp Clin Cancer Res; 1999 Sep; 18(3):403-16. PubMed ID: 10606188
[TBL] [Abstract][Full Text] [Related]
54. Reverse transcriptase-polymerase chain reaction amplification of MDR1 gene expression in adult soft tissue sarcomas.
Oda Y; Schneider-Stock R; Ryś J; Gruchała A; Niezabitowski A; Roessner A
Diagn Mol Pathol; 1996 Jun; 5(2):98-106. PubMed ID: 8727096
[TBL] [Abstract][Full Text] [Related]
55. Diagnostic Utility and Limitations of Immunohistochemistry of p16, CDK4, and MDM2 and Automated Dual-color In Situ Hybridization of MDM2 for the Diagnosis of Challenging Cases of Dedifferentiated Liposarcoma.
Kobayashi A; Sakuma T; Fujimoto M; Jimbo N; Hirose T
Appl Immunohistochem Mol Morphol; 2019; 27(10):758-763. PubMed ID: 31145104
[TBL] [Abstract][Full Text] [Related]
56. [Fusion-related round and spindle cell sarcomas of the bone (beyond Ewing)].
Vanhersecke L; Linck PA; Le Loarer F
Ann Pathol; 2022 Apr; 42(3):227-241. PubMed ID: 35216845
[TBL] [Abstract][Full Text] [Related]
57. Diagnostic Immunohistochemistry for Soft Tissue and Bone Tumors: An Update.
Schaefer IM; Hornick JL
Adv Anat Pathol; 2018 Nov; 25(6):400-412. PubMed ID: 30134255
[TBL] [Abstract][Full Text] [Related]
58. GLI1-altered mesenchymal tumor: a clinicopathological and molecular analysis of ten additional cases of an emerging entity.
Liu J; Mao R; Lao IW; Yu L; Bai Q; Zhou X; Wang J
Virchows Arch; 2022 May; 480(5):1087-1099. PubMed ID: 34779913
[TBL] [Abstract][Full Text] [Related]
59. Adult NTRK-rearranged spindle cell neoplasms of the viscera: with an emphasis on rare locations and heterologous elements.
Tsai JW; Lee JC; Hsieh TH; Huang SC; Lee PH; Liu TT; Kao YC; Chang CD; Weng TF; Li CF; Lin JC; Liang CW; Su YL; Chang IY; Wang YT; Chang NY; Yu SC; Wang JC; Huang HY
Mod Pathol; 2022 Jul; 35(7):911-921. PubMed ID: 35149769
[TBL] [Abstract][Full Text] [Related]
60. Subclassification of pleomorphic sarcomas: How and why should we care?
Hornick JL
Ann Diagn Pathol; 2018 Dec; 37():118-124. PubMed ID: 30340082
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]